Thrombolytic
Pregnancy: Relative contraindication — individualised risk-benefit
Alteplase (tPA)
Brand names: Actilyse
Adult dose
Dose: 0.9 mg/kg (max 90 mg): 10% as IV bolus over 1 min, remainder as IV infusion over 60 min
Route: IV
Frequency: Single dose
Max: 90 mg
Ischaemic stroke only, within 4.5 hours of onset. Contraindicated if haemorrhagic stroke, recent surgery, active bleeding, BP >185/110 uncontrolled.
Paediatric dose
Route: IV
Frequency: Not licensed in children for ischaemic stroke
Max: N/A
Concentration: 1 mg/ml
Not routinely used in paediatric ischaemic stroke. Specialist guidance required.
Dose adjustments
Renal
No dose adjustment required.
Hepatic
Use with caution in severe hepatic impairment.
Clinical pearls
- Door-to-needle time target: <60 minutes
- Monitor BP every 15 min during and 2 hours after infusion
- Hold antihypertensives before treatment unless BP >185/110
- Stop infusion if severe headache, acute hypertension, or neurological deterioration
Contraindications
- Haemorrhagic stroke
- Recent intracranial surgery or trauma
- Intracranial neoplasm
- Uncontrolled hypertension (>185/110)
- Active internal bleeding
- Platelet count <100,000
- Current anticoagulation with INR >1.7
Side effects
- Haemorrhage (including intracranial)
- Angioedema
- Nausea and vomiting
- Hypotension
- Reperfusion arrhythmias
Interactions
- Anticoagulants — increased bleeding risk
- Antiplatelet agents — increased bleeding risk
- NSAIDs — increased bleeding risk
Monitoring
- BP every 15 min during infusion
- Neurological status
- Signs of bleeding
- NIHSS score
Reference: BNFc; BNF; NICE NG128 Stroke and TIA. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS